prod:prod_dcx-login
Xpert® C. difficile/Epi
Detection and differentiation of C. difficile & the epidemic 027 strain in <45 minutes
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
10 Tests
GXCDIFF/EPI-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Collection devices
Collection Device (Pack of 50)
900-0370
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Single Use Disposable Swab (Pack of 120)
SDPS-120
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support
The Need
- 55% of the C. difficile cases are acquired in health care settings (Health care–associated C. difficile infection, HA-CDI)1
- It is associated with an increase in length of hospital stay, high morbidity and mortality resulting in both societal and financial burden2
- Although the accurate and rapid diagnosis of CDI is essential for effective and timely treatment, this remains an unmet clinical need or opportunity for future study in high risk patient populations4
1 Vered L, et al. Health care–associated Clostridioides difficile infection: Learning the perspectives of health care workers to build successful strategies. Am. Jour. of Infec. Con. Volume 52, Issue 3, March 2024, Pages 284-292.
2 Tschudin-Sutter S, et al. Guidance document for prevention of C. difficile infection in acute healthcare settings. Clin Microbiol Infect 2018;24:1051
4 Bai Y, Hao Y, Song Z, Chu W, Jin Y, Wang Y. Evaluation of the Cepheid Xpert C. difficile diagnostic assay: an update meta-analysis. Braz J Microbiol. 2021 Dec;52(4):1937-1949.
2 Tschudin-Sutter S, et al. Guidance document for prevention of C. difficile infection in acute healthcare settings. Clin Microbiol Infect 2018;24:1051
4 Bai Y, Hao Y, Song Z, Chu W, Jin Y, Wang Y. Evaluation of the Cepheid Xpert C. difficile diagnostic assay: an update meta-analysis. Braz J Microbiol. 2021 Dec;52(4):1937-1949.
The Solution
- The Xpert C. difficile/Epi test detects the toxin B (tcdB) gene sequence of toxigenic Clostridioides difficile & differentiates the presumptive 027/NAP1/BI-associated markers, in <45 minutes from unformed stool specimen
- Timely detection and differentiation of Clostridioides difficile (CDI) & the epidemic 027 strain optimizes patient management decisions and supports infection control and outbreak prevention measures
The Impact
Rapid and accurate molecular PCR detection of toxigenic C. difficile is essential to aid diagnostic assessment, support bed management and help reduce opportunities for transmission and outbreaks. It has been associated with*:
– 45% reduction empiric therapy5
– 48%reduction in contact precautions after a negative result6
– 45% reduction empiric therapy5
– 48%reduction in contact precautions after a negative result6
5 Peppard W, et al. Implementation of polymerase chain reaction to rule out C. difficile infection is associated with reduced empiric antibiotic duration of therapy. Hosp Pharm. 2014 Jul;49(7):639-43.
6 Guinta MM, et al. Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile. Ann Clin Microbiol Antimicrob. 2017;16(1):77. Published 2017 Dec 4. doi:10.1186/s12941-017-0252-7
* These outcomes have been reported in the literature. The Xpert® C. difficile/Epi test is intended as an aid in the diagnosis of CDI and is not intended to guide treatment or patient management decisions
Related Products
Xpert MRSA NxG
Accurate and fast on-demand PCR testing for MRSA surveillance in 70 minutes or less
Xpert SA Nasal Complete
Detection of S. aureus and MRSA in about 65 minutes
Xpert MRSA/SA Blood Culture
MRSA and S. aureus detection from gram-positive blood culture samples in 62 minutes
Xpert Norovirus
Fast detection of Norovirus GI & GII with results available in 90 minutes
Xpert vanA
Rapid VRE screening for active outbreak prevention and control in around 48 minutes
Xpert Carba-R
Detection and differentiation of KPC, NDM, VIM, IMP-1, and OXA-48 in 50 minutes
Xpert MRSA/SA SSTI
Detect MRSA & SA Skin and Soft Tissue Infections In 62 minutes